|
(V535) |
Heterozygous genomic deficiency of long noncoding RNA MALAT1 causes innate immunity deregulation and accelerated atherosclerosis development in Apo E-/- mice |
| |
|
W. Poller, M. Gast, B. H. Rauch, S. Nakagawa, A. Stroux, C. Skurk, J. Haas, B. Meder, U. Rauch-Kröhnert, T. Zeller, U. Landmesser (Berlin, Greifswald, Heidelberg, Hamburg; Sapporo, JP) |
|
|
Diskussion |
|
(V536) |
Differences in perivascular lymphangiogenesis and the expression of regulatory factors may contribute to human coronary atherosclerosis. |
| |
|
I. Drosos, M. Del Pilar Ortega Carrillo, K. Buschmann, M. Bochenek, C.-F. Vahl, T. Münzel, S. Konstantinides, K. Schäfer (Mainz) |
|
|
Diskussion |
|
(V537) |
CD27 co-stimulation fosters regulatory T cell survival and ameliorates progression of atherosclerosis |
| |
|
N. Gerdes, H. Winkels, S. Meiler, C. Weber, E. Lutgens (München) |
|
|
Diskussion |
|
(V538) |
NADPH oxidase 5 specifically mediates hyperglycemia-induced aberrant monocyte function: Potential role of Nox5 in hyperglycemia-induced atherosclerosis |
| |
|
S. Kallipatti Shanmuganathan, C. Adam, N. Müller, U. A. Müller, F.-D. Böhmer, R. Godfrey, J. Waltenberger (Münster, Jena) |
|
|
Diskussion |
|
(V539) |
Adenosine-to-inosine RNA editing controls cathepsin K expression in atherosclerotic heart disease by coupling pre-mRNA processing with mRNA stability |
| |
|
M. Sachse, A. Gatsiou, K. Stamatelopoulos, F. F. Lunella, C. Amrhein, A. M. Zeiher, S. Dimmeler, K. Stellos (Frankfurt am Main; Athens, GR) |
|
|
Diskussion |
|
(V540) |
PI3-Kinase δ-deficiency in regulatory T cells causes aggravated atherosclerosis in LDLR-/- Mice |
| |
|
M. Zierden, C. Millarg, M. Vantler, E. M. Berghausen, S. Baldus, S. Rosenkranz (Köln) |
|
|
Diskussion |